CROMSOURCE
, an international full service contract research organization (CRO) today announced the completion and opening of a new office building in Warsaw, Poland and the movement of key company services to this location.
‘Poland has been a key location for CROMSOURCE since our inception in 1994 ', noted Oriana Zerbini MD, Chief Executive Officer of CROMSOURCE. ‘We have a very large team in Poland which is a key country for delivery of our clinical projects. Our unique expertise in Poland and other Central and Eastern European countries provides our sponsors with the opportunity to complete their projects in a high quality, cost competitive and high enrolling environment. This is in large part due to the wide network of expert and committed investigators with whom CROMSOURCE has established a strong relationship based on mutual trust. I am delighted to announce that our long term project to continually develop our presence in Poland continues with the completed construction of our new offices in Warsaw and the relocation of our general company services there.’
Wanda Malkowska, Managing Director of CROMSOURCE sp. z o.o stated ‘In 2011 we rejected options to lease new premises and instead initiated a plan to invest in the construction of a new office building in Warsaw to accommodate our growing team in Poland. This project, which was entirely self-financed, has now been completed successfully and I can report that the move proceeded without any adverse impact on our operations or service to our clients.’
The new office is located in the Żoliborz district of Warsaw, only 4km (2.5 miles) from the city center and just 12km (7.5 miles) from Chopin airport. The office space is greater than 1000m2 (10,750 ft2) and incorporates a secure basement for archiving and storage. The building will house functions including Clinical Operations, Staffing Solutions, Human Resources Recrutiment & Selection, Accounting, Finance. This is also the location of Financial Service Center Unit that manages all invoicing, accounting and project administration activities for all Group entities following standardised procedures developed over many years.
About CROMSOURCE: CROMSOURCE is a high quality ISO-certified international provider of outsourced services to the pharmaceutical, biotechnology and medical device industries, specialized in clinical development and staffing solutions. CROMSOURCE was founded in 1994 and is unique in guaranteeing our clients that their trials will be delivered on time and within the contract price (our End-to-End guarantee).
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.